Consonance Capital Management LP / RCUS
Consonance Capital Management LP’s Arcus Biosciences Inc Position
Does Consonance Capital Management LP own Arcus Biosciences Inc (RCUS)? Not currently — the last reported position was 387.5K shares worth $10M in Q4 2020; the fund’s latest 13F (Q3 2022) no longer reports it.
Position Value
$10M
Q4 2020
Shares
387.5K
% of Portfolio
+0.94%
Quarters Held
1
position exited
Position History RCUS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2020 | 387.5K | $10M | +0.94% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of RCUS.